Scientific Advisory Board
Jeffrey Cummings MD
Director of Cleveland Clinic Lou Ruvo Center for Brain Health and Professor of Neurotherapeutics and Drug Development, Cleveland Clinic.
Hoau-Yan Wang PhD
Tenured Medical Professor at CUNY Medical School; co-lead scientist on discovery & development of PTI-125 and SavaDx.
Steven E. Arnold MD
Translational Neurology Head of the Interdisciplinary Brain Center, Massachusetts General Hospital, Harvard Medical School.
Trevor W. Robbins CBE FRS FMedSci
Professor of Cognitive Neuroscience at the University of Cambridge and Past President of the British Neuroscience Association.
Barbara J. Sahakian FBA, FMedSci
Professor of Clinical Neuropsychology at the Department of Psychiatry and Medical Research Council /Wellcome Trust Behavioral and Clinical Neuroscience Institute, University of Cambridge.
Robert Gussin PhD
Dr. Gussin worked at Johnson & Johnson for 26 years, most recently as Chief Scientific Officer and Corporate Vice President, Science and Technology from 1986 through his retirement in 2000.
Patrick Scannon MD, PhD
Founder and former previous Executive Vice President, Chief Biotechnology Officer of Xoma Corporation.